LABT is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.
LABT is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.
Over the past 52 weeks, Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) has traded between a low of $2.10 and a high of $98.20.
LABT is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.
Yes. Kraken offers a secure, highly liquid and intuitive way to buy 11,000+ stocks, ETFs and commodities. With advanced trading tools built for both indvidual investors and professional institutions, Kraken offers an all-in-one way to invest in cryptocurrencies, stocks, ETFs and the most important assets for your financial future.
The first step for new invstors looking to buy stocks is to a secure, reputable and competitive stock trading platform such as Kraken. After opening and funding your account. From there, it can be helpful to first research Lakewood-Amedex and its recent market performance, From there, Kraken makes it easy to buy fractional shares of Lakewood-Amedex so you can start small and build your portfolio over time.
Yes. Kraken’s mobile app allows you to buy, sell, and manage Lakewood-Amedex trades on the go from your smartphone.
Earnings reports, product launches, economic data, sector performance, and broad market conditions all influence the price movement of Lakewood-Amedex stock.
No. Kraken makes it easy to buy fractional shares of Lakewood-Amedex, meaning you do not need to purchase a full share in order to add Lakewood-Amedex to your portfolio.
